knowledge -WSS

knowledge

author：comprehensive 2025-09-07 21:52:18 - browse：6

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Readout LOUD podcast, live from the STAT Breakthrough Summit East

WSS

Yancopoulos of Regeneron works to expand Dupixent success

6 surprising facts about sugar

U.K. officials, researchers try to ease path for bespoke genetic treatments

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Texas board proposes rules on abortion law emergency exemption

Yancopoulos of Regeneron works to expand Dupixent success

hotspot

knowledge

hotspot

Apple is now the first public company to be valued at $3 trillion

Cancer, immunology, HIV research ensnared in fetal tissue politics

Novavax promises a turnaround & Lilly roils the obesity market

'Patient friction coefficient' can gauge a clinical trial's patient burden

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Illumina, CRISPR, Regeneron

Alkermes shareholders re

Medical devices makers are asking for forgiveness, not permission

Medical records are filled with copy

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

focus

5 dead in mass shooting on Caribbean island of St. Vincent: Police

How a Boston hospital is priming medical residents to use GPT

Caribou posts encouraging results on off

In rare move, senator releases unverified FBI source report alleging Biden bribe

Delta passengers in Vegas fall sick while waiting on flight in triple

Sanders wants to replace patents with prizes for drug inventions

Wikipedia

hotspot

Wikipedia

focus